Evexia Lifecare reported 54% revenue growth to ₹865.90 lakh but net profit declined 36.85% to ₹72.79 lakh amid operational challenges and auditor concerns.
The company convened its 34th AGM on May 15, 2026 to approve financial statements, reappoint directors, and authorize loans and investments up to ₹2000 crores.
Auditors reported multiple adverse observations including improper fixed asset records, unassessed impairment of investments, and inadequate documentation for related party transactions.
Significant FCCB conversions increased share capital from ₹70.80 crores to ₹187.73 crores while preferential warrants were issued to promoter group companies.